The International Foundation Against Infectious Disease in Nigeria is a research non-profit dedicated to generating locally grounded evidence that protects children and strengthens Africa's health systems.
Who We Are
IFAIN was established to address critical gaps in locally generated evidence on infectious diseases affecting Nigerian and African children. Since 2012, we have evolved from a focused research group into a multidisciplinary institution spanning microbiology, molecular diagnostics, genomic surveillance, epidemiologic research, and public health capacity development.
We work in close partnership with leading academic institutions, government health bodies, and international funders to produce science that is both globally rigorous and locally relevant.
Our Vision
"To be the leading hub for innovative research driving effective and sustainable prevention and control of infectious diseases in Nigeria and Africa."
Our History
From a single founding study to a multi-programme, internationally funded research institution.
IFAIN joins the Global Vaccine Data Network's BRAVE project — establishing Nigeria as a key site for Lassa fever vaccine development.
Two major multi-site studies activated simultaneously, marking IFAIN's largest concurrent research portfolio.
UK Fleming Fund awards country grant for One Health AMR surveillance — implemented in partnership with Liverpool School of Tropical Medicine.
Expansion into mobile health platforms for Sickle Cell Disease surveillance alongside the first AMR characterisation studies in paediatric populations.
Secure electronic data capture infrastructure established, enabling auditable, internationally compliant data management across all sites.
CAPIBD study launched in partnership with the University of Nebraska Medical Center — the first major NIH-funded study on community-acquired pneumonia and invasive bacterial disease in Nigerian children.
Prof. Stephen Obaro establishes IFAIN in Abuja to address the critical gap in locally generated evidence on paediatric infectious disease in Nigeria.
Research Focus
Five interconnected research domains contributing to reducing the burden of infectious disease.
Bacteraemia, pneumonia, meningitis and sepsis in children under five — with a focus on pathogen identification, treatment outcomes, and prevention strategies.
Characterisation of AMR patterns across human, animal, and environmental health sectors using genomic and molecular methods.
Background adverse event rate studies and vaccine-preventable disease surveillance to support evidence-based immunisation policy.
Capacity building in clinical microbiology, molecular diagnostics, and biosurveillance within Nigeria's health system.
Governance
IFAIN operates under a clear governance framework designed to safeguard scientific integrity, ethical conduct, and institutional accountability.
Board of Trustees
Chief Scientific Officer / Founder
MBBS, FWACP, MRCP(UK), FRCPCH, FAAP, PhD, FIDSA, FPIDSA
Chairman of Board
PhD, FWAPCP
Trustee
JCA
Trustee
MBBS MPH FWACP Dip HSM
Trustee
B.Sc Computer Science, MBA
Trustee
LLB, MBA
Governance Assurance
For full team profiles and qualifications visit the Our Team page →
Ethics & Compliance
All IFAIN research is conducted in full accordance with Nigerian national and international ethical, regulatory, and governance standards. Every study undergoes prior approval from appropriately constituted Health Research Ethics Committees.
All human subjects research conducted under formal ethics approval with rigorous informed consent and participant protection maintained throughout.
Comprehensive data management ensuring participant confidentiality, data integrity, and responsible stewardship aligned with international best practice.
Sound financial management ensuring transparency, accountability, and appropriate stewardship of all donor and grant funding.
All activities fully documented and traceable, supporting compliance with Nigerian and international regulatory requirements.
Partners & Funders
IFAIN works alongside leading academic institutions, global health organisations, pharmaceutical companies, and government bodies.
DS-I Africa
Data ScienceNational Institutes of Health
Research Funder
Global Vaccine Data Network
Research
Wellcome Sanger Institute
Research
GSK
Pharmaceutical
J. Craig Venter Institute
Genomics
University of Ibadan
Academic
University of Maryland, School of Medicine
Research
GAVI, The Vaccine Alliance
ResearchWe welcome enquiries from funders, researchers, ethics bodies, and health organisations worldwide.